CIK 0001815974
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Anebulo Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ANEB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851170950
- Phone
- +1 737-203-5270
- Business address
- C/O ANEBULO PHARMACEUTICALS, INC., 1017 RANCH ROAD 620 SOUTH, SUITE 107, LAKEWAY, TX, 78734
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-04 | Lin Kenneth Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2025-04-04 | Lin Kenneth Director | Grant or award · Stock Option (right to buy) | +4,964 | 4,964 | ||
| 2024-06-13 | Lin Kenneth Director | Grant or award · Stock Option (right to buy) | +41,667 | 41,667 | ||
| 2024-06-13 | Lin Kenneth Director | Grant or award · Stock Option (right to buy) | +2,482 | 2,482 | ||
| 2022-04-21 | Lin Kenneth Director | Grant or award · Stock Option (right to buy) | +30,425 | 30,425 |
Page 1 of 1 · 5 trades